Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 5.86 -0.17% -0.01
CEMI closed down 0.17 percent on Monday, March 18, 2019, on 70 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CEMI trend table...

Date Alert Name Type % Chg
Mar 18 Lizard Bullish Bullish Day Trade Setup 0.00%
Mar 18 Doji - Bullish? Reversal 0.00%
Mar 18 Lower Bollinger Band Walk Weakness 0.00%
Mar 18 Outside Day Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Bullish Engulfing Bullish -0.17%
Mar 15 Calm After Storm Range Contraction -0.17%
Mar 15 Lower Bollinger Band Walk Weakness -0.17%
Mar 15 Inside Day Range Contraction -0.17%
Mar 15 Lower Bollinger Band Touch Weakness -0.17%

Older signals for CEMI ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Medicine Medical Specialties Immunology Infectious Diseases Antibodies Immune System Antibody Medical Tests Diagnostic Tests Technology Products HIV Hiv/Aids Ortho Clinical Diagnostics Retail Establishments Diagnosis Of Hiv/Aids
Is CEMI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 11.55
52 Week Low 4.85
Average Volume 46,592
200-Day Moving Average 8.5755
50-Day Moving Average 6.6994
20-Day Moving Average 6.5035
10-Day Moving Average 6.153
Average True Range 0.2819
ADX 37.4
+DI 8.1417
-DI 32.7794
Chandelier Exit (Long, 3 ATRs ) 6.2443
Chandelier Exit (Short, 3 ATRs ) 6.4957
Upper Bollinger Band 7.4154
Lower Bollinger Band 5.5916
Percent B (%b) 0.15
BandWidth 28.043361
MACD Line -0.2523
MACD Signal Line -0.1473
MACD Histogram -0.105
Fundamentals Value
Market Cap 72.13 Million
Num Shares 12.3 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -8.25
Price-to-Sales 4.04
Price-to-Book 4.83
PEG Ratio -0.47
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.24
Resistance 3 (R3) 6.21 6.05 6.17
Resistance 2 (R2) 6.05 5.96 6.07 6.15
Resistance 1 (R1) 5.96 5.90 6.01 5.99 6.13
Pivot Point 5.80 5.80 5.83 5.82 5.80
Support 1 (S1) 5.71 5.71 5.76 5.74 5.59
Support 2 (S2) 5.55 5.65 5.57 5.57
Support 3 (S3) 5.46 5.55 5.55
Support 4 (S4) 5.49